Literature DB >> 7553633

Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin 6.

M Okamoto1, H Kawamata, K Kawai, R Oyasu.   

Abstract

Chronic inflammation of the urinary tract is a significant risk factor for the development of bladder cancer. We have shown that acute and chronic inflammation induced by intravesical instillations of killed Escherichia coli strikingly enhances N-methyl-N-nitrosourea (MNU)-initiated rat bladder carcinogenesis. To test the hypothesis that cytokines released during inflammation may be involved in the enhancement of bladder carcinogenesis, we conducted an in vitro experiment. Using soft agar growth as an index of transformation, we examined the effect of inflammation-associated cytokines on the enhancement of MNU-initiated transformation of MYP3 cells, an anchorage-dependent nontumorigenic rat bladder epithelial cell line. In the first experiment, after 1-h exposure to MNU (50 micrograms/ml), cells (5 x 10(4)) were grown in soft agar in the presence of interleukin (IL)-1 alpha, IL-6, IL-8, or tumor necrosis factor-alpha (10 to 100 ng/ml). Colonies consisting of more than 20 cells were counted 4 weeks later. Among the cytokines tested, IL-6 (100 ng/ml) significantly increased colony counts over those for the untreated controls (P < 0.001). In the second experiment, the cells treated with MNU similarly as in the first experiment were cultured with or without IL-6 (100 ng/ml) for 1 week before the cells (5 x 10(4)) were grown in soft agar in the presence or absence of IL-6. IL-6 pretreatment increased colony counts irrespective of subsequent IL-6 treatment (P < 0.05). Moreover, IL-6-stimulated anchorage-dependent growth of MNU transformants far exceeded that of the parental MYP3. However, among the transformants, there was no parallel relationship in response to IL-6 between anchorage-dependent and -independent growth. Our results suggest that IL-6 may provide a selective growth advantage to MNU-initiated bladder epithelial cells in vitro and that it may be a factor accounting for the marked enhancement of inflammation-associated rat bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553633

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  BCG response prediction with cytokine gene variants and bladder cancer: where we are?

Authors:  Dinesh Kumar Ahirwar; Parmeet Kaur Manchanda; Rama Devi Mittal; Hemant K Bid
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-20       Impact factor: 4.553

2.  Gene Variants in Predicting BCG Response to Urinary Bladder Cancer.

Authors:  Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2012-02-11

3.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

4.  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.

Authors:  Paul Zarogoulidis; Lonny Yarmus; Kaid Darwiche; Robert Walter; Haidong Huang; Zhigang Li; Bojan Zaric; Kosmas Tsakiridis; Konstantinos Zarogoulidis
Journal:  Immunome Res       Date:  2013-08-12

5.  Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.

Authors:  S Fujii; T Fujimori; H Kawamata; J Takeda; K Kitajima; F Omotehara; T Kaihara; T Kusaka; K Ichikawa; Y Ohkura; Y Ono; J Imura; S Yamaoka; C Sakamoto; Y Ueda; T Chiba
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.

Authors:  Isabelle Bekeredjian-Ding; Meike Schäfer; Evelyn Hartmann; Ralph Pries; Marijo Parcina; Philip Schneider; Thomas Giese; Stefan Endres; Barbara Wollenberg; Gunther Hartmann
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

7.  Torque teno virus (SANBAN isolate) ORF2 protein suppresses NF-kappaB pathways via interaction with IkappaB kinases.

Authors:  Hong Zheng; Linbai Ye; Xiaonan Fang; Baozong Li; Yuhua Wang; Xiaoxiao Xiang; Lingbao Kong; Wei Wang; Yinchun Zeng; Li Ye; Zhenghui Wu; Yinglong She; Xiaolin Zhou
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

8.  To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator.

Authors:  Daniela Sorriento; Maddalena Illario; Rosa Finelli; Guido Iaccarino
Journal:  Transl Med UniSa       Date:  2012-10-11

9.  Long-term exposure to cigarette smoke extract induces hypomethylation at the RUNX3 and IGF2-H19 loci in immortalized human urothelial cells.

Authors:  Li-Mei Chen; Jennifer C Nergard; Liqiang Ni; Charles J Rosser; Karl X Chai
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

Review 10.  Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases.

Authors:  Nayely Leyva-López; Erick P Gutierrez-Grijalva; Dulce L Ambriz-Perez; J Basilio Heredia
Journal:  Int J Mol Sci       Date:  2016-06-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.